FDA Updates Labeling on Febrile Seizure Risks i...

By João L. Carapinha

January 19, 2026

FDA Labeling Mandate on Febrile Seizure Risks In a significant update to vaccine safety protocols, the U.S. Food and Drug Administration (FDA) has required pediatric influenza vaccines t...
Antidepressant Side Effects: New Insights on Cardiometabolic Health Risks
AI Chatbot Delusions: Navigating the Risks of Validation in Mental Health
Medicare ACO Outcomes: Balancing Surgical Benefits and Costs Under the TEAM M...
High Orphan Drug Prices Persist Despite Market Exclusivity Expiration
Promising Results for Peanut Oral Immunotherapy
AI Patient Education: Evaluating ChatGPT and Gemini for Pediatric Condition M...
Cervical Self-Sampling Methods: Overcoming Barriers
MPA Meningioma Risk: Key Insights and Implications
Thyroid Cancer Diagnosis: Delays During the Pandemic, Implications and Trends
Battling Antimicrobial Resistance in Northwest Syria: A Call for Urgent Action
Diabetes in the MENA Region: Challenges and Solutions
Ozempic Shows Promise in Reducing Alzheimer’s Risk